Why Drug Price Negotiation Has Staying Power

(By Drew Altman for Kaiser Family Foundation, published June 25, 2021)

The fact that prescription drugs represent just 10% of national health spending may make it seem like not an especially important target for health care cost containment efforts. But the idea keeps coming back and is in the spotlight on Capitol Hill right now.  Continue reading the article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org